ࡱ> :<9%` bjbj"x"x ,@@ 00000004d,,,,\ d `i i i | ~ ~ ~ ~ ~ ~ 9hd~ 0 i i   ~ 00     00|   |   00  Џ,  h  0    0 di ^ K L i i i ~ ~ i i i     dddhdddhddd000000 Third Annual Advances In Chemical Sciences Symposium sponsored by NESACS, IUPAC and RSC-US Royal Sonesta Hotel, Cambridge, MA 9:00 a.m. April 10, 2009 This day long scientific conference will focus on Medicinal 91AV Organic Synthesis Methodology Eminent scientists from industry and academia will deliver plenary lectures. Confirmed Lecturers include: Melanie Sanford, University of Michigan Pd(II/IV)-Catalyzed Reactions in Organic Synthesis Alison Frontier, University of Rochester "New Twists on the Nazarov Cyclization Christopher Straub, Novartis Institutes for BioMedical Research Sympathy for the Devil: Taking IAP Antagonists from Research to the Clinic Andreas Goutopoulos, EMD Serono "The Discovery of Novel Allosteric MEK Inhibitors as Potential Anticancer Agents" Michael Barbachyn, AstraZeneca Pharmaceuticals "Challenges in the Discovery of New Antibacterial Agents" Scott Snyder, Columbia University "Lessons in Chemoselectivity: Total Synthesis of Polyphenolic Natural Products" The symposium will be followed by a networking reception and vendor exhibition Symposium registration fee: $ 50.00 or $25 for Students Vendors please contact the Organizing Committee Attendance is Limited Advanced Registration is REQUIRED Please send your full contact information along with your check for $50 made payable to NESACS to Marilou Cashman Administrative Secretary, NESACS, 23 Cottage Street, Natick, MA 01760 For additional details, including sponsorship and exhibition opportunities contact any of the Organizing Committee:  HYPERLINK "mailto:Chorghade@comcast.net" Chorghade@comcast.net  HYPERLINK "mailto:Scott.Cowen@Astrazeneca.com" Scott.Cowen@Astrazeneca.com  HYPERLINK "mailto:Gurmit.Grewal@Astrazeneca.com" Gurmit.Grewal@Astrazeneca.com  HYPERLINK "mailto:Gabriel.Martinez-Botella@Astrazeneca.com" Gabriel.Martinez-Botella@Astrazeneca.com  HYPERLINK "mailto:Kristin.Rosner@SPcorp.com" Kristin.Rosner@SPcorp.com  HYPERLINK "mailto:JMcKew@Wyeth.com" JMcKew@Wyeth.com  HYPERLINK "mailto:RalphScannell@AmuletPharma.com" RalphScannell@AmuletPharma.com  HYPERLINK "mailto:Jamedio@Ziopharm.com" Jamedio@Ziopharm.com  HYPERLINK "mailto:rrajur@creagenbio.com" rrajur@creagenbio.com  HYPERLINK "mailto:Leslie.McQuire@Novartis.com" Leslie.McQuire@Novartis.com  HYPERLINK "mailto:Yanhong.Li@Pfizer.com" Yanhong.Li@Pfizer.com  HYPERLINK "mailto:Bayard.Huck@EMDSerono.com" Bayard.Huck@EMDSerono.com  HYPERLINK "mailto:MPollast@BU.edu" MPollast@BU.edu   45ABZ[\oq~Ͳ{aJa03h-dhsm(5B*CJOJPJQJ\^JaJph-hfH5B*CJ OJPJQJ\^JaJph3hsm(hsm(5B*CJ OJPJQJ\^JaJph3h-dhsm(5B*CJ OJPJQJ\^JaJph9h-dhsm(56B*CJ,OJPJQJ\]^JaJ!ph5hsm(hsm(56B*CJ,OJPJQJ\]^Jph3h-dhsm(5B*CJOJPJQJ\^JaJph/hsm(hsm(5B*CJOJPJQJ\^Jph      $a$gd**䴳ʴϴ^-(*䴳ʴϴ.ӼӝӼiӼӴ<jhah+B*CJOJPJQJU^JaJph<jhah+B*CJOJPJQJU^JaJph(hah+0JCJOJPJQJ^JaJ<jhah+B*CJOJPJQJU^JaJph-hRh+B*CJOJPJQJ^JaJph'h+B*CJOJPJQJ^JaJph0jh+B*CJOJPJQJU^JaJph>뵜󜇜<jhah+B*CJOJPJQJU^JaJph<jhah+B*CJOJPJQJU^JaJph(hah+0JCJOJPJQJ^JaJ0jh+B*CJOJPJQJU^JaJph<jhah+B*CJOJPJQJU^JaJph-hRh+B*CJOJPJQJ^JaJph'h+B*CJOJPJQJ^JaJph$&'(FGHI\prstԵԜhIԜ<jxhah+B*CJOJPJQJU^JaJph<jhah+B*CJOJPJQJU^JaJph(hah+0JCJOJPJQJ^JaJ0jh+B*CJOJPJQJU^JaJph<jhah+B*CJOJPJQJU^JaJph'h+B*CJOJPJQJ^JaJph-hRh+B*CJOJPJQJ^JaJph 3HJKLabcdwԵԜhԜI<j! hah+B*CJOJPJQJU^JaJph<jF hah+B*CJOJPJQJU^JaJph(hah+0JCJOJPJQJ^JaJ0jh+B*CJOJPJQJU^JaJph<jShah+B*CJOJPJQJU^JaJph'h+B*CJOJPJQJ^JaJph-hRh+B*CJOJPJQJ^JaJphץ׋ h ' hR$hah+0JCJOJPJQJ^J8j hah+B*CJOJPJQJU^Jph)h+h+B*CJOJPJQJ^Jph#h+B*CJOJPJQJ^Jph,jh+B*CJOJPJQJU^Jph 21h:psm(/ =!"#$% U 01h:p+/ =!"#$% P0 0 0 0 5 01h:p+/ =!"#$% DyK Chorghade@comcast.netyK :mailto:Chorghade@comcast.netDyK Scott.Cowen@Astrazeneca.comyK Fmailto:Scott.Cowen@Astrazeneca.comDyK Gurmit.Grewal@Astrazeneca.comyK Jmailto:Gurmit.Grewal@Astrazeneca.com'DyK )Gabriel.Martinez-Botella@Astrazeneca.comyK `mailto:Gabriel.Martinez-Botella@Astrazeneca.comDyK Kristin.Rosner@SPcorp.comyK Bmailto:Kristin.Rosner@SPcorp.comDyK JMcKew@Wyeth.comyK 0mailto:JMcKew@Wyeth.comDyK RalphScannell@AmuletPharma.comyK Lmailto:RalphScannell@AmuletPharma.comDyK Jamedio@Ziopharm.comyK 8mailto:Jamedio@Ziopharm.comDyK rrajur@creagenbio.comyK :mailto:rrajur@creagenbio.comDyK Leslie.McQuire@Novartis.comyK Fmailto:Leslie.McQuire@Novartis.comDyK Yanhong.Li@Pfizer.comyK :mailto:Yanhong.Li@Pfizer.comDyK Bayard.Huck@EMDSerono.comyK Bmailto:Bayard.Huck@EMDSerono.comDyK MPollast@BU.eduyK .mailto:MPollast@BU.eduJ@J ]xNormal dCJ_HaJmH sH tH DA@D Default Paragraph FontRiR 0 Table Normal4 l4a (k( 0No List 6U@6 R Hyperlink >*B*phH@H  I Balloon TextCJOJQJ^JaJ ,4,, @0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0 Z00JSZ00Z00X00Z00Z00j    F\^Ajl'FHs   K a c XXXXXXXXXXXXX8@0(  B S  ? 'Bܬ'B$'BD'B$'B4O'B$h'Bѭ'B'B<=T W 9*urn:schemas-microsoft-com:office:smarttagsState=*urn:schemas-microsoft-com:office:smarttags PlaceType=*urn:schemas-microsoft-com:office:smarttags PlaceName9*urn:schemas-microsoft-com:office:smarttagsplace? *urn:schemas-microsoft-com:office:smarttags stockticker ^ bi  FP$-yNUV] gh 3 y l- ' ]xg+#sm(fHpjM IqMR4-)+